Other Industries
NVIDIA: The Rocket Fuel Boosting BIODND to Build the Most Advanced Integrated Data Platform in Biotech
TAIPEI, Dec. 19, 2024 – Artificial intelligence (AI) is evolving faster than ever, and its fusion with biotechnology and data science is sparking a game-changing revolution in the global biotech industry. Recently, GeneOnlineannounced that its proprietary integrated data platform, BIODND, has offici...
BioAro and GeneOnline Forge Partnership to Revolutionize Genetic Analysis in Asia Pacific Market
BioAro, a Canadian-based genetic testing company, is excited to announce a strategic partnership with GeneOnline, a premier biotechnology market intelligence and media company. This partnership aims to accelerate the growth and development of the genetic testing market and data analysis across the A...
Taiwan’s Biotech and Pharma Delegation: Innovations Take Center Stage at BIO 2024
Taiwan's biotechnology industry is making a significant impact at the 2024 BIO International Convention in San Diego. Organized by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) under the Ministry of Economic Affairs, the Taiwan delegation includes representatives from vari...
Cooperation and Innovation in Navigating the Next Generation of Precision Medicine: Driving the Future of the Biotech Industry
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem with over 18,500 industry leaders from around the world. Organized by the Biotechnology Innovation Organization (BIO), the convention is held annually in major U.S. cities ...
VarioDB: AI Dictionary and Applications in Marketing
Artificial Intelligence (AI) is advancing at an extraordinary pace, permeating every corner of life, and the marketing industry is no exception. AI has tremendous potential to revolutionize how businesses approach and attract customers, opening up new opportunities for the industry's development. T...
Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform
- SupportingRakuten Medical’s efforts to accelerate its global Phase 3 studywith the goal of achieving approval of ASP-1929 in US as soon as possible - Also supporting development of additional pipeline using the Alluminox™ platform, including ASP-1929 photoimmunotherapy in combination with anti-P...
Comparing ESG Regulations in the U.S., the U.K., and the EU
Environmental, social, and corporate governance (ESG) is a rapidly evolving framework designed to hold companies accountable for their actions and increase understanding of how an organization or company manages its risks around these issues. In a perfect world, ESG knowledge would increase investor...
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
Born and raised in Japan, Takashi “Tora” Toraishi has a master's degree and a Ph.D. from the University of Tokyo, in nuclear chemistry. Before he joined Rakuten Medical, Tora worked in the molecular biology and chemistry field. He acted as a partner for McKinsey & Company, providing management consu...
2023 Trend Forecast: Transforming Healthcare with Real-world Data and Personalized Medicine
By the end of 2022, while the global COVID-19 pandemic seemed to be subsiding, the development of the biotech and healthcare industry has kept up its pace over the past three years. Rather, consolidation efforts have been accelerated in specific areas, especially the integration of healthcare and te...
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
The Institute of Biological Chemistry (IBC), Academia Sinica, National Taiwan University Hospital (NTUH), and BIOTOOLS hosted the 7th annual Asia Microbiome Conference (AMC) on January 7th, 2023, at Academia Sinica, Taiwan. With over 400 hundred domestic and foreign microbiome experts participating ...
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
Established in February 2020, Micronbrane Medical is a Taiwan-based biotechnology startup company dedicated to the development of precision medicine. With an international team of scientists, engineers and innovators, the company is focused on the development of clinical pathogen diagnostic a...
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
PHILADELPHIA –RemeGenattended the American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2022, from Nov 10-14, to present promising phase III trial data for SLE which met its primary endpoint, and phase II trial data for primary Sjogren’s syndrome which showed encouraging sa...
Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare
It is no news that the childbirth rate is declining each year. However, you might not realize that it has reached a point where the number of pets is more than the number of children under the age of 15 for the first time in Taiwan’s history in 2020. What’s more, according to Taiwan’s Pets Re...
RemeGen Looks to Take Next Global Steps During ASN Kidney Week 2022
ORLANDO, FL – RemeGen officials look to partner with a global pharmaceutical or biotech company to take their drug candidates to the next level during ASN Kidney Week 2022. “Having seen a lot of promising data having emerged from the completed, or even ongoing trials, it really brings us to looking...
Moving Past Animal Models with Better Data for Drug Discovery
With the FDA Modernization Act’s passage earlier this year, drug developers have the opportunity to forgo animal models in preclinical development for the first time in history. While the bill provides reprieve for the millions of animals tested in laboratories, it also provides a chance for human a...
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
“How does vision become reality?” Illumina CEO Francis deSouza posed this question at the beginning of the 2022 Illumina Genomics Forum hosted in San Diego, California. The first day of the four-day event saw deSouza’s introduction of the importance of genomics, followed by a panel hosted by Nobel L...
Coastar Therapeutics Receives Venture Capital Investment to Further Develop Delivery Technology of Biologics for Cancer and Gene Therapies
SAN DIEGO, Calif., November 10, 2022 — Coastar Therapeutics, a biotechnology company and emerging leader in biologic drug delivery technology, today announced it has successfully completed the first close of its Series Pre-A financing. The multi-million dollar investment was led by Panacea Venture a...
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene
The recent progress in cell and gene therapies, particularly that of autologous CAR-T therapy, has brought revolutionary advances to medicine. However, due to the variability of the donor source and manufacturing processes, these new treatments come with financial limitations and safety concerns. Gl...
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy
Head and neck cancer, the seventh largest cancer globally, typically arises from the head and neck region, with 90% of the carcinoma originating from squamous cells. Since head and neck cancer includes cancers in various subsites, like the tongue, pharyngeal, laryngeal, and nasal cavities, the sympt...
BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry
BIOPLUS-INTERPHEX KOREA (BIX) was held from August 3-5 in person at COEX, Seoul. With the theme, K-BIO Value Chain, the event encompasses biopharmaceutical value chains, including R&D, manufacturing process, logistics, packaging, CMO/CDMO, AI, and big data. In the opening ceremony, Christopher Han...
Week's Top Stories
Most Reposted
COCONEXT 2024 - FIRST EVER INTERNATIONAL COCONUT CONFERENCE HOLD IN VIETNAM
[Picked up by 298 media titles]
2024-12-31 14:18Dahua Technology Obtains ISO 37301 Compliance Management System Certification
[Picked up by 281 media titles]
2024-12-30 15:33Interest-Driven Consumption Sparks ¥ 500B ACG Goods Market, MINISO Rides the Wave
[Picked up by 276 media titles]
2025-01-03 19:33Russell Reynolds Associates Appoints Euan Kenworthy as Singapore Country Manager
[Picked up by 276 media titles]
2025-01-02 08:16CKGSB Professor Mei Jianping Launches Global Indices Tracking Impressionist, Contemporary, and Chinese Art Markets
[Picked up by 258 media titles]
2024-12-31 22:30